摘要
目的探讨拉咪夫定联合小剂量高价人乙肝免疫球蛋白方案预防肝移植术后乙肝病毒再感染的临床疗效。方法回顾性研究21例乙肝病毒相关终末期肝病患者行肝移植术后联合应用拉咪夫定、小剂量高价人乙肝免疫球蛋白的临床资料,分析总结该方案对预防肝移植术后乙肝病毒再感染的疗效。结果2例肝移植术后发生乙肝病毒再感染,其余19例病毒标志物检查为阴性。结论拉咪夫定联合小剂量高价人乙肝免疫球蛋白方案可经济、有效地预防乙肝病毒相关终末期肝病肝移植术后乙肝病毒再感染。
Objective To investigate the effect of combined antiviral therapy with lamivudine and low-dose HBIg on reinfection of hepatitis B virus (HBV) in orthotopic liver transplantation (OLT) recipients. Methods The clinical data of 21 liver transplantation recipients were analyzed retrospectively. Result Two recipients reinfected by HBV, and other patients showed negative serum HBV. Conclusion Lamivudine combined with low-dose HBIg may be useful in preventing the reinfection of HBV after OLT.
出处
《重庆医学》
CAS
CSCD
2007年第11期1065-1066,1068,共3页
Chongqing medicine